搜索临床试验以:TPN171H 2.5mg组
总计10872个结果
-
Chelsea and Westminster NHS Foundation TrustGilead Sciences; Imperial College London终止
-
Novartis Pharmaceuticals完全的继发于病理性近视 (PM) 的脉络膜新生血管 (CNV) 导致的视力障碍中国, 印度, 泰国, 香港, 大韩民国, 菲律宾
-
Oslo University HospitalUniversity Hospital, Aker完全的
-
University of Texas Southwestern Medical Center完全的
-
Samjin Pharmaceutical Co., Ltd.完全的
-
Weill Medical College of Cornell UniversityGilead Sciences主动,不招人
-
Eivind MelandUniversity of Agder完全的
-
Kansai Electric Power HospitalMedical Corporation Heishinkai OCROM Clinic完全的
-
Peter A Campochiaro, MDGenentech, Inc.完全的
-
Boston VA Research Institute, Inc.Celgene Corporation; Edward Hines Jr. VA Hospital; Michael E. DeBakey VA Medical Center; Kansas... 和其他合作者完全的
-
Institut de Médecine et d'Epidémiologie Appliquée...Pierre and Marie Curie University招聘中
-
Oregon Health and Science UniversityNational Heart, Lung, and Blood Institute (NHLBI); Oregon Clinical and Translational Research...完全的
-
University of Southern DenmarkCenter for Kognitive Terapier og Supervision未知
-
University Medical Center Goettingen招聘中
-
Idorsia Pharmaceuticals Ltd.Janssen Biotech, Inc.完全的
-
CHA UniversityHanlim Pharm. Co., Ltd.完全的